This seems pretty interesting.
Hypertrophic Cardiomyopathy is an excessive thickening of the heart muscle, which blocks the flow of blood out of the heart and to the rest of the body. It is thought to be a major cause of sudden heart failure deaths among athletes and young people. The alcohol treatment, developed and put into practice at the Bikur Holim hospital in Jerusalem, involves the injection of alcohol (97%) directly into the blood vessels supplying the engorged area of the muscle. This injection cuts off supply of blood to the specific area affected, thus lessening the blockage of the exit valve of the heart's left ventricle. The alcohol injection has thus far led to improved cardiac performance in 90% of the heart patients so treated, eliminating the need for dangerous surgical alternatives.
Bikur Holim Hospital did not pioneer the new treatment for hypertrophic cardiomyopathy, as stated in yesterday's report. The treatment was in fact developed in England in 1994.
That seems like quite a mistake!